Trevi Therapeutics, Inc. Annual Interest Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Trevi Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2018 to 2023.
  • Trevi Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $1K, a 99.3% decline year-over-year.
  • Trevi Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $9K, a 99.1% decline year-over-year.
  • Trevi Therapeutics, Inc. annual Interest Expense for 2023 was $391K, a 66.4% decline from 2022.
  • Trevi Therapeutics, Inc. annual Interest Expense for 2022 was $1.16M, a 3.25% decline from 2021.
  • Trevi Therapeutics, Inc. annual Interest Expense for 2021 was $1.2M, a 164% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $391K -$772K -66.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $1.16M -$39K -3.25% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $1.2M +$746K +164% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $456K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2018 $174K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.